BioWound Solutions Selected to Exhibit Keramatrix at Vizient Innovative Technology Exchange

Keramatrix is an innovative FDA 510(k) cleared keratin-based wound dressing indicated for a wide range of wounds, including pressure ulcers.

LAS VEGAS, Sept. 23, 2026 /PRNewswire/ -- BioWound Solutions, Inc. ("BioWound Solutions") today announced it has been selected to exhibit Keramatrix^®, an advanced keratin-based wound matrix indicated for dry, light and moderately exudating partial and full thickness wounds, including pressure injuries, at the Vizient^® Innovative Technology Exchange. Vizient, the nation's largest provider-driven healthcare performance improvement company, will hold the Exchange Sept. 24 in Las Vegas. Keramatrix is owned and exclusively distributed by BioWound Solutions.

The annual Innovative Technology Exchange offers selected suppliers the unique opportunity to demonstrate their product or service to supply chain and clinical leaders from Vizient's hospital clients and subject matter experts who serve on their supply councils. Each product or service will showcase how it improves clinical outcomes, enhances safety or drives incremental improvements to healthcare delivery or business models.

Keramatrix is a naturally derived keratin wound matrix designed to stimulate keratinocytes and support the body's natural healing processes. Its unique keratin-based structure provides clinicians with a versatile, easy-to-use option with a wide range of indications, including pressure injuries up to Stage 4. By promoting cellular activity that aids healing, Keramatrix is designed to help advance wound closure and improve outcomes for patients with difficult-to-heal wounds while supporting more efficient wound care practices. As an FDA 510(k) cleared device, providers can match the diagnosis to a wide range of Indication for Use, streamlining treatment algorithms. Keramatrix is a prescription use device.

"The Innovative Technology Exchange provides a distinctive platform for healthcare providers to engage with products and services that may influence the healthcare landscape and enhance clinical care or organizational business models," said Kelly Flaharty, associate vice president of contract operations, Vizient. "We are pleased to extend an invitation to BioWound Solutions to participate in the Exchange."

The annual Innovative Technology Exchange is part of Vizient's Innovative Technology Program that includes product review of supplier-submitted technologies by provider-led councils. Since 2003, Vizient has reviewed over 1,700 product submissions as part of its Innovative Technology Program.

About BioWound Solutions

BioWound Solutions, headquartered in Las Vegas, Nevada, is a leading wound solutions company that partners with hospitals, health systems, and post-acute providers to improve outcomes across the full spectrum of acute and chronic wounds, with particular expertise in the prevention and management of pressure injuries. Through a comprehensive portfolio of advanced wound care technologies, BioWound enables clinicians to select therapies tailored to each patient's unique wound characteristics. The company complements its product portfolio with its proprietary AI-powered Eligibility Engine™ for real-time benefits verification, clinical education, reimbursement support, and market access resources that help providers simplify care delivery, standardize protocols, and improve operational efficiency. By combining innovative technologies with hands-on clinical partnerships, BioWound Solutions helps healthcare organizations advance healing, improve patient outcomes, and strengthen wound care programs nationwide.

MEDIA CONTACT

SOURCE Biowound Solutions LLC